Tharimmune, Inc. (NASDAQ: THAR), a publicly traded company seeking to leverage Canton Coin (“CC”) to support the Canton Network’s digitization of traditional financial markets, announced the successful closing of its previously announced private placement resulting in aggregate gross proceeds of approximately $545.0 million, before placement agent fees and offering expenses.
The offering consisted of shares of common stock (or par-value pre-funded warrants in lieu thereof) priced at $3.075 per share and was completed with institutional and strategic investors.
Net proceeds from the offering are expected to be used to acquire Canton Coin, the utility token supporting interoperability and settlement across the Canton Network, and to support the Company’s plans to operate as a Super Validator and additional Validators on the network. Remaining proceeds are expected to be used for working capital and general corporate purposes.
Clear Street acted as sole placement agent and financial advisor in connection with the offering. President Street Global served as financial advisor. Lucosky Brookman LLP and Sheppard Mullin Richter & Hampton LLP served as counsel to Tharimmune, Inc. Paul Hastings LLP served as counsel to Clear Street, and Reed Smith LLP served as counsel to DRW in connection with the transaction.
